A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.
Also called NCT03099122
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 115 participants
- Sponsor
- Registry
-
NCT03099122
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03099122. Allocation not applicable; no masking; primary purpose prevention. Start 2017-08-16 (actual); primary completion 2019-11-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant
- Acronym
- START-DCD
- Condition
- End-stage Renal Disease
- Intervention (Biological)
- Rabbit Anti-thymocyte Immunoglobulin
- Intervention (Drug)
- Tacrolimus
- Intervention (Drug)
- Methylprednisolone
- Intervention (Drug)
- Mycophenolate mofetil
- Intervention (Drug)
- Mycophenolate Na
- Intervention (Drug)
- prednisone
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct03099122- Content hash
a075e6091173955cce282a85a3c334274c4a885cc945c651fbec0cffd8ea2ab3